Showing results (101-110 of 3,467) with videos related to
Sort By:
Pageof 347
Clinical Pharmacokinetics|January 1, 1976
Pathophysiological and disease-induced changes in drug distribution volume: pharmacokinetic implicationsU KlotzClinical Pharmacokinetics|September 1, 1994
Clinical pharmacokinetic advantages of new drug delivery methods for the treatment of liver tumoursJ H Anderson, H W Warren, C S McArdleClinical Pharmacokinetics|September 1, 1994
Assessment of liver metabolic function. Clinical implicationsJ Brockmöller, I RootsClinical Pharmacokinetics|November 26, 2023
Impact of Key Components of Intensified Ceftaroline Dosing on Pharmacokinetic/Pharmacodynamic Target AttainmentIris K Minichmayr, Sebastian G Wicha, Peter Matzneller, et al.Clinical Pharmacokinetics|November 20, 2023
Population Pharmacokinetic/Pharmacodynamic Analysis of the Glucokinase Activator PB201 in Healthy Volunteers and Patients with Type 2 Diabetes Mellitus: Facilitating the Clinical Development of PB201 in ChinaLing Song, Fangrui Cao, Shu Niu, et al.Clinical Pharmacokinetics|November 2, 2023
Evolution of Ritlecitinib Population Pharmacokinetic Models During Clinical Drug DevelopmentJessica Wojciechowski, Vivek S Purohit, Yeamin Huh, et al.Clinical Pharmacokinetics|August 30, 2023
Pharmacokinetics of Oral Vitamin D in Children with Obesity and AsthmaJason E Lang, Rodrigo Gonzalez Ramirez, Stephen Balevic, et al.Clinical Pharmacokinetics|October 24, 2023
The Pharmacokinetics of the Nonsteroidal Mineralocorticoid Receptor Antagonist FinerenoneRoland Heinig, Thomas EissingClinical Pharmacokinetics|October 6, 2023
Pharmacokinetics and Tolerability of Zibotentan in Patients with Concurrent Moderate Renal and Moderate Hepatic ImpairmentAnne-Kristina Mercier, Mikael Sunnåker, Sebastian Ueckert, et al.Clinical Pharmacokinetics|July 5, 2023
Unraveling Complexities in the Absorption and Disposition Kinetics of Abiraterone via Iterative PBPK Model Development and RefinementEleanor Jing Yi Cheong, Sheng Yuan Chin, Zheng Wei Ng, et al.Pageof 347